2011, Number 26
<< Back Next >>
Hipoc Rev Med 2011; 6 (26)
Pitiriasis Rosada: aspectos generales, bases para el diagnóstico y tratamiento
Jiménez-Cornejo MC, González-de la Torre S
Language: Spanish
References: 7
Page: 12-14
PDF size: 132.43 Kb.
ABSTRACT
Pityriasis rosea is an inflammatory dermatosis characterized by a single lesion, followed
by a flaky and erythematous rash. It is more common in women and usually
appears in an age range from 10 to 35 years. Its etiology is unknown but it has been
associated with Herpes Viruses type 6 and 7. Histopathological findings include spongiotic
dermatitis and parakeratosis. It is a self-limited disease, however if the itching
and discomfort are important topical glucocorticoid and oral antihistamine can be
given, concerning the use of sulfone and systemic corticosteroids is controversial.
REFERENCES
1.- Arenas, R., Dermatología, altas, diagnóstico y tratamiento,, Mc Graw Hill, Segunda edición Cap. 116, Págs. 407-410.
2.- Drago F, Broccolo F, Rebora A. Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology. J Am Acad Dermatol. 2009 Aug;61(2):303-18.
3.- Veguillas Gil S., Zambrano Centeno B., Alonso Pacheco ML., Pitiriasis Rosada, Diagnóstico por imagen, Departamento de Dermatología, Hospital General Universitario de Guadalajara Págs. 234-235.
4.- Stulberg DL, Wolfrey J. Pityriasis rosea. Am Fam Physician. 2004 Jan 1;69(1):87-91.
5.- Lee Harris N., F. Mc- Neely W., A 33 year old man with a rash, pulmonary infection, and neurologic disorder, Case Records of the Massachusetts General Hospital, N Eng J Med, October 25 2001.
6.- Drago F, Rebora A. Treatments for pityriasis rosea.Skin Therapy Lett 2009 Mar;14(3):6-7.
7- Chuh AA, Dofitas BL, Comisel GG, Reveiz L, Sharma V, Garner SE, Chu F. Interventions for pityriasis rosea. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005068.